Long-term follow-up and biomarker analyses of brentuximab vedotin and dhap in relapsed/refractory hodgkin lymphoma patients: the hovon/llpc transplant brave studyJulia Driessen,Marie-Jose Kersten,Lydia Visser,A. P. van den Berg,J. M. Zijlstra,Sanne H. Tonino, G.J.C. Zwezerijnen,Ronald Boellaard,Pieternella J. Lugtenburg,Martin Hutchings,Marcel Nijland,Roberto D Liu,F. Morschhauser,Pauline Brice,Thomas Gastinne,D. de Jong,Anton Hagenbeek,Wouter J. Plattel,Arjan DiepstraHematological Oncology（2021）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
